当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析

益佰制药

(600594)

  

流通市值:27.16亿  总市值:27.16亿
流通股本:7.92亿   总股本:7.92亿

益佰制药(600594)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.74亿元,每股收益-0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益277677.56万元,未分配利润90204.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产416715.75万元,负债139038.19万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,713,840,317.371,168,191,423.5572,646,100.112,820,561,015
营业总成本1,842,847,294.111,265,385,630.58635,203,702.042,621,425,841.6
营业利润-163,471,482.03-106,432,218.92-67,731,162.14137,357,956.51
利润总额-173,766,399.26-114,024,543.41-69,765,713.72132,320,704.64
净利润-174,241,819.86-110,973,983.57-71,411,782.7891,357,121.13
其他综合收益27,008.8339,540.8339,540.83-343,624.32
综合收益总额-174,214,811.03-110,934,442.74-71,372,241.9591,013,496.81
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,732,617,097.291,943,499,023.392,035,731,291.562,069,148,018.19
非流动资产合计2,434,540,393.752,462,359,121.942,486,967,016.642,528,105,844.99
资产总计4,167,157,491.044,405,858,145.334,522,698,308.24,597,253,863.18
流动负债合计867,216,658.471,067,252,716.751,073,036,097.08929,589,640.18
非流动负债合计523,165,200.58483,552,120.29502,779,494.19649,409,264.12
负债合计1,390,381,859.051,550,804,837.041,575,815,591.271,578,998,904.3
归属于母公司股东权益合计2,648,055,698.322,725,723,383.532,816,029,216.992,884,444,484.61
股东权益合计2,776,775,631.992,855,053,308.292,946,882,716.933,018,254,958.88
负债和股东权益合计4,167,157,491.044,405,858,145.334,522,698,308.24,597,253,863.18
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,067,422,269.771,492,763,687.85769,767,157.873,160,484,140.26
经营活动现金流出小计1,867,618,947.161,289,666,943.49674,012,608.92,782,874,327.7
经营活动产生的现金流量净额199,803,322.61203,096,744.3695,754,548.97377,609,812.56
投资活动现金流入小计12,293,621.4111,518,621.4111,508,509.9364,788,124.46
投资活动现金流出小计68,679,525.8948,336,191.5522,157,326.31180,382,397.82
投资活动产生的现金流量净额-56,385,904.48-36,817,570.14-10,648,816.38-115,594,273.36
筹资活动现金流入小计380,000,000238,784,183.37148,000,000741,328,819.18
筹资活动现金流出小计611,209,313.27367,520,000.97161,974,530.49893,019,030.8
筹资活动产生的现金流量净额-231,209,313.27-128,735,817.6-13,974,530.49-151,690,211.62
汇率变动对现金及现金等价物的影响-12,532---
现金及现金等价物净增加额-87,804,427.1437,543,356.6271,131,202.1110,325,327.58
期末现金及现金等价物余额607,876,290.72733,224,074.48766,811,919.96695,680,717.86
TOP↑